Please login to the form below

Not currently logged in
Email:
Password:

e-Therapeutics appoints new CEO

Dr Raymond Barlow joins firm from Amgen

UK-based drug discovery and development firm e-Therapeutics appoints Dr Raymond Barlow as its new CEO.

Prior to e-Therapeutics, Barlow worked for a number of global pharma companies, including AstraZeneca as its director of corporate development and most recently at Amgen working on deals with Boehringer Ingelheim, GlaxoSmithKline and Geneta.

He said: “e-therapeutics is at the forefront of a new wave of science and has created a unique, computational-based drug discovery platform. This platform uses a range of truly cutting-edge technologies, including artificial intelligence.

“I am looking forward to engaging with our key stakeholders as well as subsequently positioning and promoting the company to an industry which needs the assets and solutions we can provide.”

10th April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics